Sidewinder Therapeutics
Pioneering next-generation bispecific ADCs for cancer treatment.
Technology stack
detected 2026-05-23Company Timeline
What does Sidewinder Therapeutics do?
Sidewinder Therapeutics is pioneering the next generation of bispecific antibody-drug conjugates (ADCs) designed to expand the therapeutic window for patients with difficult-to-treat cancers. Their engineered ADCs target receptor co-complexes highly expressed on solid tumors, aiming for enhanced tumor cell specificity and internalization. The company is built by a team of entrepreneurs, scientists, and drug developers committed to delivering these advanced therapies.
How much funding has Sidewinder Therapeutics raised?
Sidewinder Therapeutics has raised a total of $137M in funding. The most recent round on record is Series B.
Where is Sidewinder Therapeutics headquartered?
Sidewinder Therapeutics is headquartered in San Diego, California, USA.
When was Sidewinder Therapeutics founded?
Sidewinder Therapeutics was founded in 2026.
What industry does Sidewinder Therapeutics operate in?
Sidewinder Therapeutics operates in Biotechnology, Pharmaceuticals, Oncology, Drug Discovery.
How many employees does Sidewinder Therapeutics have?
Sidewinder Therapeutics has approximately 9 people on record.